search
Back to results

Implementation of CBT-I in Cancer Clinics

Primary Purpose

Insomnia

Status
Recruiting
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Web-based cognitive-behavioral therapy for insomnia (CBT-I)
Professionally-administered booster face-to-face CBT-I sessions
Sponsored by
CHU de Quebec-Universite Laval
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Insomnia focused on measuring Insomnia, Cancer, Cognitive-behavioral therapy, Stepped care model, Self-administered treatment, Web-based intervention, Implementation, Cost-effectiveness

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • have received a diagnosis of non-metastatic cancer (any type)
  • to be aged 18 years and older
  • to be readily able to read and understand French or English
  • having the minimum cognitive abilities to read, understand and memorize information
  • having access to Internet

Exclusion Criteria:

  • having a psychological comorbidity needing clinical attention (e.g., major depressive disorder)
  • having severe cognitive impairments (e.g., diagnosis of Parkinson's disease, dementia)
  • having insomnia due to a temporary condition (e.g., acute pain, short-term medication side effects, environmental factors)

Sites / Locations

  • Centre de recherche de L'Hôtel-Dieu de QuébecRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Stepped care CBT-I

Arm Description

Outcomes

Primary Outcome Measures

Implementation (organizational) measures
Referral, enrolment and completion rates to the stepped care CBT-I in each clinical setting.
1) Efficiency (patients) measures
Change in Insomnia Severity Index Scores from pre- to post-intervention. The ISI is a 7-item questionnaire designed to evaluate insomnia severity. A score greater than or equal to 8 indicates the presence of insomnia symptoms.
2) Efficiency (patients) measures
Change in daily sleep diary parameters from pre- to post-intervention: Change in sleep efficiency (SE) index (%) = Total sleep time/total time spent in bed X 100.
3) Efficiency (patients) measures
Change in daily sleep diary parameters from pre- to post-intervention: Change in sleep onset latency (SOL) = Time to sleep after lights out.
4) Efficiency (patients) measures
Change in daily sleep diary parameters from pre- to post-intervention: Change in wake after sleep onset (WASO) = Summation of nocturnal awakenings.
5) Efficiency (patients) measures
Change in daily sleep diary parameters from pre- to post-intervention: Change in total wake time (TWT) = Summation of SOL, WASO, and early morning awakening.
6) Efficiency (patients) measures
Change in daily sleep diary parameters from pre- to post-intervention: Change in total sleep time (TST) = Time in bed minus total wake time.
7) Efficiency (patients) measures
Change scores from pre to post-intervention: Hospital Anxiety and Depression Scale (HADS): A 14-item questionnaire comprising 7 items assessing depression and 7 items assessing anxiety. Scores obtained for each subscale range from 0 to 21.
8) Efficiency (patients) measures
Change scores from pre to post-intervention: Fatigue Symptom Inventory (FSI): A 14-item questionnaire measuring perceived fatigue. Each item is rated on an 11-point Likert scale, ranging from 0 to 10. A higher score indicates a higher level of fatigue or interference or a longer duration of fatigue.
9) Efficiency (patients) measures
Change scores from pre to post-intervention: The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): A 30-item questionnaire. Scores are transformed to give a score ranging from 0 to 100.
10) Efficiency (patients) measures
Change scores from pre to post-intervention: Satisfaction with Life Scale (SWLS): A 5-item questionnaire (Likert scale from 1 to 7) designed to measure global cognitive judgments of satisfaction with one's life.
1) Fidelity to the treatment protocol (psychologists)
Self-assessed adherence to the CBT-I protocol (%)
2) Fidelity to the treatment protocol (psychologists)
Perceived self-efficiency in using CBT-I protocol (%)

Secondary Outcome Measures

1) Possible predictors of a better program uptake
Clinicians and patients' demographics (e.g., age, sex)
2) Possible predictors of a better program uptake
Administrators' and clinicians' attitude towards empirically-based treatments (Evidence-Based Practice Attitudes Scale (EBPAS; 15 items)): Scores obtained range from 0 to 60.
3) Possible predictors of a better program uptake
Stress at work (Workplace Stress Scale (WSS; 8 items)): Scores obtained range from 8 to 40.
4) Possible predictors of a better program uptake
Attitude towards change (Organizational Readiness for Implementing Change (ORIC; 12 items)): Participants rated the hospital's readiness for implementation on 12 items using a 5-point ordinal scale that ranged from "disagree" (1) to "agree" (5).
5) Possible predictors of a better program uptake
Clinicians' CBT expertise (number of years of experience with CBT)
6) Possible predictors of a better program uptake
Patients' familiarity with the Internet (Internet Evaluation and Utility Questionnaire (IEUQ; 15 items)): Patients respond to the questions on a 5-point likert scale from "not at all" (0) to "very" (4), with 2 open-ended items asking patients to identify "most helpful" and "least helpful" parts of the web program.
7) Possible predictors of a better program uptake
Health literacy (Brief Health Literacy Screening Tool (BRIEF; 4 items)): Each item ranges from 1 to 5 and total scores range from 4 to 20.
Possible moderating treatment effect by some of the participants' characteristics (e.g., age, sex, cancer site).

Full Information

First Posted
March 18, 2021
Last Updated
July 18, 2022
Sponsor
CHU de Quebec-Universite Laval
Collaborators
Canadian Institutes of Health Research (CIHR), Canadian Cancer Society (CCS)
search

1. Study Identification

Unique Protocol Identification Number
NCT04817163
Brief Title
Implementation of CBT-I in Cancer Clinics
Official Title
Implementation of a Stepped Care Cognitive-Behavioral Therapy for Insomnia in Routine Cancer Care
Study Type
Interventional

2. Study Status

Record Verification Date
July 2022
Overall Recruitment Status
Recruiting
Study Start Date
December 13, 2019 (Actual)
Primary Completion Date
May 30, 2023 (Anticipated)
Study Completion Date
May 30, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
CHU de Quebec-Universite Laval
Collaborators
Canadian Institutes of Health Research (CIHR), Canadian Cancer Society (CCS)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Insomnia affects 30-60% of cancer patients, thus making it one of the most common disturbances in this population. When untreated, which is the rule rather than the exception, insomnia often becomes chronic. Chronic insomnia is associated with numerous negative consequences (e.g., increased risk for psychological disorders, health care costs). A large body of evidence supports the efficacy of cognitive-behavioral therapy for insomnia (CBT-I) in cancer patients, but CBT-I is still not offered routinely in cancer clinics. Self-administered CBT-I (e.g., video-based intervention) has been developed to increase patients' access to this treatment. However, results of clinical trials have suggested that these minimal treatments would be better used as a first step of a stepped care model. In stepped care, patients receive only the level of intervention they need. Generally, the entry level is a minimal, less costly, intervention (e.g., self-help intervention) followed by a more intensive form of treatment if needed (if the patient is still symptomatic). The investigators have recently assessed the efficacy of a stepped care model to administer CBT-I in cancer patients, which includes a web-based CBT-I (called Insomnet) followed by up to 3 sessions with a psychotherapist if the patient is still symptomatic. Results of this study suggest that this model of care is non-inferior to a standard face-to-face treatment (Savard, Ivers, et al., in revision), while being more cost-effective. A stepped care CBT-I could therefore be offered in routine cancer care clinics. This project will assess the feasibility and effectiveness of implementing a stepped care CBT-I in real-world cancer clinics, using a non-randomized stepped wedge design to compare the effects of our program (active phase) with a passive phase. The program is called Insomnia in Patients with Cancer - Personalized Treatment (IMPACT). The stepped care CBT-I (active intervention) is being implemented sequentially in the four participating hospitals over a number of equally spaced time periods of 4 months (wedges), for a total of 5 time points, over a period of 20 months.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Insomnia
Keywords
Insomnia, Cancer, Cognitive-behavioral therapy, Stepped care model, Self-administered treatment, Web-based intervention, Implementation, Cost-effectiveness

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Sequential Assignment
Model Description
The stepped care CBT-I (active intervention) is being implemented sequentially in the four participating hospitals over a number of equally spaced time periods of 4 months (wedges), for a total of 5 time points, over a period of 20 months.
Masking
None (Open Label)
Allocation
N/A
Enrollment
120 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Stepped care CBT-I
Arm Type
Experimental
Intervention Type
Behavioral
Intervention Name(s)
Web-based cognitive-behavioral therapy for insomnia (CBT-I)
Other Intervention Name(s)
Self-administered
Intervention Description
Each week, the patients first have to read written information on the website (www.insomnet.ca), and then watch a video capsule (duration between 5 and 20 min each). Patients complete their daily sleep diary electronically on the website and the content is interactive. It includes the sending of automated emails to remind participants to complete the treatment tasks and encourage adherence, provision of tailored feedback (e.g., texts, charts) based on the information that they provide in their sleep diary, as well as quizzes with automated correction to reinforce patients' understanding of the content.
Intervention Type
Behavioral
Intervention Name(s)
Professionally-administered booster face-to-face CBT-I sessions
Intervention Description
Patients who obtain an ISI score of 8 and more after completing the web-based CBT-I are "stepped up" and offered to receive up to three 50-min booster sessions of CBT-I offered individually by a psychologist (if needed). Remitted patients (good sleepers; ISI score lower than 8) will receive no further treatment.
Primary Outcome Measure Information:
Title
Implementation (organizational) measures
Description
Referral, enrolment and completion rates to the stepped care CBT-I in each clinical setting.
Time Frame
Passive phase (4 months) vs. active phase (20 months), through study completion, an average of 24 months
Title
1) Efficiency (patients) measures
Description
Change in Insomnia Severity Index Scores from pre- to post-intervention. The ISI is a 7-item questionnaire designed to evaluate insomnia severity. A score greater than or equal to 8 indicates the presence of insomnia symptoms.
Time Frame
Pre-treatment and post-treatment (6-8 weeks later)
Title
2) Efficiency (patients) measures
Description
Change in daily sleep diary parameters from pre- to post-intervention: Change in sleep efficiency (SE) index (%) = Total sleep time/total time spent in bed X 100.
Time Frame
Pre-treatment and post-treatment (6-8 weeks later)
Title
3) Efficiency (patients) measures
Description
Change in daily sleep diary parameters from pre- to post-intervention: Change in sleep onset latency (SOL) = Time to sleep after lights out.
Time Frame
Pre-treatment and post-treatment (6-8 weeks later)
Title
4) Efficiency (patients) measures
Description
Change in daily sleep diary parameters from pre- to post-intervention: Change in wake after sleep onset (WASO) = Summation of nocturnal awakenings.
Time Frame
Pre-treatment and post-treatment (6-8 weeks later)
Title
5) Efficiency (patients) measures
Description
Change in daily sleep diary parameters from pre- to post-intervention: Change in total wake time (TWT) = Summation of SOL, WASO, and early morning awakening.
Time Frame
Pre-treatment and post-treatment (6-8 weeks later)
Title
6) Efficiency (patients) measures
Description
Change in daily sleep diary parameters from pre- to post-intervention: Change in total sleep time (TST) = Time in bed minus total wake time.
Time Frame
Pre-treatment and post-treatment (6-8 weeks later)
Title
7) Efficiency (patients) measures
Description
Change scores from pre to post-intervention: Hospital Anxiety and Depression Scale (HADS): A 14-item questionnaire comprising 7 items assessing depression and 7 items assessing anxiety. Scores obtained for each subscale range from 0 to 21.
Time Frame
Pre-treatment and post-treatment (6-8 weeks later)
Title
8) Efficiency (patients) measures
Description
Change scores from pre to post-intervention: Fatigue Symptom Inventory (FSI): A 14-item questionnaire measuring perceived fatigue. Each item is rated on an 11-point Likert scale, ranging from 0 to 10. A higher score indicates a higher level of fatigue or interference or a longer duration of fatigue.
Time Frame
Pre-treatment and post-treatment (6-8 weeks later)
Title
9) Efficiency (patients) measures
Description
Change scores from pre to post-intervention: The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): A 30-item questionnaire. Scores are transformed to give a score ranging from 0 to 100.
Time Frame
Pre-treatment and post-treatment (6-8 weeks later)
Title
10) Efficiency (patients) measures
Description
Change scores from pre to post-intervention: Satisfaction with Life Scale (SWLS): A 5-item questionnaire (Likert scale from 1 to 7) designed to measure global cognitive judgments of satisfaction with one's life.
Time Frame
Pre-treatment and post-treatment (6-8 weeks later)
Title
1) Fidelity to the treatment protocol (psychologists)
Description
Self-assessed adherence to the CBT-I protocol (%)
Time Frame
Throughout the active phase, up to 20 months
Title
2) Fidelity to the treatment protocol (psychologists)
Description
Perceived self-efficiency in using CBT-I protocol (%)
Time Frame
Throughout the active phase, up to 20 months
Secondary Outcome Measure Information:
Title
1) Possible predictors of a better program uptake
Description
Clinicians and patients' demographics (e.g., age, sex)
Time Frame
Pre-treatment and post-treatment (6-8 weeks later) for patient; Through study completion (an average of 24 months) for clinicians
Title
2) Possible predictors of a better program uptake
Description
Administrators' and clinicians' attitude towards empirically-based treatments (Evidence-Based Practice Attitudes Scale (EBPAS; 15 items)): Scores obtained range from 0 to 60.
Time Frame
Through study completion, an average of 24 months
Title
3) Possible predictors of a better program uptake
Description
Stress at work (Workplace Stress Scale (WSS; 8 items)): Scores obtained range from 8 to 40.
Time Frame
Through study completion, an average of 24 months
Title
4) Possible predictors of a better program uptake
Description
Attitude towards change (Organizational Readiness for Implementing Change (ORIC; 12 items)): Participants rated the hospital's readiness for implementation on 12 items using a 5-point ordinal scale that ranged from "disagree" (1) to "agree" (5).
Time Frame
Through study completion, an average of 24 months
Title
5) Possible predictors of a better program uptake
Description
Clinicians' CBT expertise (number of years of experience with CBT)
Time Frame
Through study completion, an average of 24 months
Title
6) Possible predictors of a better program uptake
Description
Patients' familiarity with the Internet (Internet Evaluation and Utility Questionnaire (IEUQ; 15 items)): Patients respond to the questions on a 5-point likert scale from "not at all" (0) to "very" (4), with 2 open-ended items asking patients to identify "most helpful" and "least helpful" parts of the web program.
Time Frame
Pre-treatment and post-treatment (6-8 weeks later)
Title
7) Possible predictors of a better program uptake
Description
Health literacy (Brief Health Literacy Screening Tool (BRIEF; 4 items)): Each item ranges from 1 to 5 and total scores range from 4 to 20.
Time Frame
Pre-treatment and post-treatment (6-8 weeks later)
Title
Possible moderating treatment effect by some of the participants' characteristics (e.g., age, sex, cancer site).
Time Frame
Pre-treatment (at recruitment)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: have received a diagnosis of non-metastatic cancer (any type) to be aged 18 years and older to be readily able to read and understand French or English having the minimum cognitive abilities to read, understand and memorize information having access to Internet Exclusion Criteria: having a psychological comorbidity needing clinical attention (e.g., major depressive disorder) having severe cognitive impairments (e.g., diagnosis of Parkinson's disease, dementia) having insomnia due to a temporary condition (e.g., acute pain, short-term medication side effects, environmental factors)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Josée Savard, Ph.D.
Phone
418-525-4444
Ext
20622
Email
josee.savard@psy.ulaval.ca
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Josée Savard, Ph.D.
Organizational Affiliation
Centre de recherche du CHU de Québec-Université Laval
Official's Role
Principal Investigator
Facility Information:
Facility Name
Centre de recherche de L'Hôtel-Dieu de Québec
City
Québec
ZIP/Postal Code
G1R 2J6
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Catherine Filion, M.A.
Phone
1-418-525-4444
Ext
20618
Email
catherine.filion@crchudequebec.ulaval.ca
First Name & Middle Initial & Last Name & Degree
Josée Savard, Ph.D.
First Name & Middle Initial & Last Name & Degree
Marie-Pierre Gagnon, Ph.D.
First Name & Middle Initial & Last Name & Degree
Aude Caplette-Gingras, Ph.D.
First Name & Middle Initial & Last Name & Degree
Lynda Bélanger, Ph.D.
First Name & Middle Initial & Last Name & Degree
Charles M. Morin, Ph.D.

12. IPD Sharing Statement

Learn more about this trial

Implementation of CBT-I in Cancer Clinics

We'll reach out to this number within 24 hrs